ロード中...
Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury
Vascular endothelial growth factor pathway inhibitors (VEGFi), used as anti-angiogenic drugs to treat cancer are associated with cardiovascular toxicities through unknown molecular mechanisms. Endothelial cell-derived microparticles (ECMPs) are biomarkers of endothelial injury and are also functiona...
保存先:
| 出版年: | Cardiovasc Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452312/ https://ncbi.nlm.nih.gov/pubmed/30753341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvz021 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|